Obama, AARP announce agreement to cut prescription drug costs

On Monday, President Barack Obama joined with AARP chief Barry Rand to announce "an agreement among pharmaceutical companies to cut prescription drug costs for seniors - and inject some energy into his efforts at comprehensive health care reform," Politico reports. Obama said the companies' goal is to "to reduce the punishing inflation in health care while improving patient care."

Americans will see "brand-name drug costs cut in half," Rand said in opening remarks. He also gave a "significant endorsement to Obama's plan for health care reform," and said that he would work with the president to get a bill on his desk by the end of the year (Lee, 6/22).

 CBS Political Hotsheet: "In the deal, the Pharmaceutical Research and Manufacturers of America (PhRMA) has agreed to reduce its draw of revenues by $80 billion over 10 years by discounting the cost of medicines in Medicare's Part D prescription drug program for some seniors by as much as 50 percent. The discount would go to seniors who fall into the 'doughnut hole' - a gap in Medicare Part D coverage. Currently, once seniors have received $2,700 worth of drugs, they are left to pay the full cost of their medication until that cost reaches $6,100."

Obama said, "it's only fair" that pharmaceutical companies do their part to reduce costs because they stand to gain millions of more customers through reform efforts (Condon, 6/22).

"The president used the opportunity to make his sternest call yet for action, saying the drug agreement is one piece of 'health care reform I expect Congress to enact this year,'" the Associated Press reports (Loven, 6/22).

Dow Jones reports: "It's unclear, however, how much of the expected $80 billion in savings over 10 years will go toward paying for the proposed health-care overhaul" (Pilizzi, 6/22).

Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Louisiana reclassifies drugs used in abortions as controlled dangerous substances